Rhythm Pharmaceuticals annual operating margin
2021
2022
2023
2024
2025
Rhythm Pharmaceuticals Operating Margin Growth & History (RYTM)
Rhythm Pharmaceuticals's operating margin was −101.19% for fiscal 2025.
View full Rhythm Pharmaceuticals company overviewRhythm Pharmaceuticals annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −101.19% | +102.84 pp |
| 2024 | 2024-12-31 | −204.04% | +34.07 pp |
| 2023 | 2023-12-31 | −238.10% | +519.82 pp |
| 2022 | 2022-12-31 | −757.92% | +4633.93 pp |
| 2021 | 2021-12-31 | −5,391.85% | — |
Rhythm Pharmaceuticals quarterly operating margin
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −68.14% | +25.25 pp |
| Q1 2026 | 2026-03-31 | −87.11% | +56.62 pp |
| Q4 2025 | 2025-12-31 | −82.20% | +16.42 pp |
| Q3 2025 | 2025-09-30 | −102.64% | +29.34 pp |
| Q2 2025 | 2025-06-30 | −93.39% | +45.81 pp |
| Q1 2025 | 2025-03-31 | −143.73% | +394.99 pp |
| Q4 2024 | 2024-12-31 | −98.62% | +71.67 pp |
| Q3 2024 | 2024-09-30 | −131.98% | +63.33 pp |
| Q2 2024 | 2024-06-30 | −139.20% | +103.26 pp |
| Q1 2024 | 2024-03-31 | −538.71% | −80.68 pp |
| Q4 2023 | 2023-12-31 | −170.29% | +308.69 pp |
| Q3 2023 | 2023-09-30 | −195.31% | +721.28 pp |
| Q2 2023 | 2023-06-30 | −242.46% | +254.95 pp |
| Q1 2023 | 2023-03-31 | −458.03% | +3059.40 pp |
| Q4 2022 | 2022-12-31 | −478.99% | +2327.23 pp |
| Q3 2022 | 2022-09-30 | −916.60% | +3386.91 pp |
| Q2 2022 | 2022-06-30 | −497.42% | +14258.79 pp |
| Q1 2022 | 2022-03-31 | −3,517.42% | +94762.58 pp |
| Q4 2021 | 2021-12-31 | −2,806.22% | — |
| Q3 2021 | 2021-09-30 | −4,303.50% | — |
| Q2 2021 | 2021-06-30 | −14,756.20% | — |
| Q1 2021 | 2021-03-31 | −98,280.00% | — |
Rhythm Pharmaceuticals operating margin trends
Across the available reported history, Rhythm Pharmaceuticals's operating margin increased from −204.04% to −101.19%, a change of +102.84 percentage points. The latest reported quarter, Q2 2026, shows −68.14%.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Rhythm Pharmaceuticals filings at SEC.gov ↗